Total submissions: 19
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000036561 | SCV000060216 | benign | not specified | 2017-08-29 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000036561 | SCV000305593 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000243809 | SCV000317916 | benign | Cardiovascular phenotype | 2015-06-15 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Illumina Laboratory Services, |
RCV000290215 | SCV000353356 | likely benign | Left ventricular noncompaction cardiomyopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000345311 | SCV000353357 | likely benign | Familial restrictive cardiomyopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000404183 | SCV000353358 | likely benign | Hypertrophic cardiomyopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000304487 | SCV000353359 | likely benign | Dilated Cardiomyopathy, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000771066 | SCV000902578 | benign | Cardiomyopathy | 2018-03-15 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000860466 | SCV001000525 | benign | Hypertrophic cardiomyopathy 2; Dilated cardiomyopathy 1D; Cardiomyopathy, familial restrictive, 3 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000036561 | SCV001433175 | benign | not specified | 2019-09-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001675590 | SCV001894200 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450667 | SCV004177956 | likely benign | Dilated cardiomyopathy 1D | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450668 | SCV004177957 | likely benign | Cardiomyopathy, familial restrictive, 3 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450666 | SCV004177958 | likely benign | Hypertrophic cardiomyopathy 2 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000036561 | SCV001740917 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000036561 | SCV001920302 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000036561 | SCV001957394 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000036561 | SCV001972587 | benign | not specified | no assertion criteria provided | clinical testing | ||
Cohesion Phenomics | RCV000404183 | SCV003803644 | benign | Hypertrophic cardiomyopathy | 2022-09-27 | no assertion criteria provided | clinical testing |